ACAT · NP Life Sciences Health Industry Group Inc. · Financials
$10.00
At close · Oct 24
Going-concern doubt
— flagged Apr 16, 2024
Substantial doubt about the company's ability to continue as a going concern.
“The circumstances give rise to substantial doubt to the Company's ability to continue as a going concern within one year after the date that the financial statements are issued, and in order to remain solvent that the Company is dependent upon its ability to generate sufficient revenues to operate profitably or raise additional capital through debt financing and/or through sales of common stock. These conditions raise substantial doubt about the Company's ability to continue as a going concern. These consolidated financial statements do not include any adjustments to reflect the possible future effect on the recoverability and classification of assets or the amounts and classifications of liabilities that may result from the outcome of these uncertainties. Management believes that the actions presently being taken to obtain additional funding and implement its strategic plan provides an opportunity for the Company to continue as a going concern.”View the 10-K filed Apr 16, 2024
Market Cap
$42.96M
Shares
4.30M
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$164.62K
+61.4%
FY2023
Net Income
-$2935
+84.4%
FY2023
Operating Margin
-0.42%
+18.1pp
FY2023
Diluted EPS
$0.00
FY2023
Operating Cash Flow
-$73.61K
-178.4%
FY2023
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| $164.62K | $102K | $34.99K | $15K | $43K | |
| — | -$1 | $4 | — | — | |
| $165.31K | $120.86K | $100.67K | $146.09K | $151.86K | |
| -$690 | -$18.86K | -$65.68K | -$131.09K | -$108.86K | |
| -0.42% | -18.48% | -187.7% | -873.94% | -253.16% | |
| $645 | $1 | — | — | — | |
| — | -$1 | $4 | — | — | |
| -$1335 | -$18.86K | -$65.68K | -$131.07K | -$108.83K | |
| $1600 | — | — | — | — | |
| -$2935 | -$18.86K | -$65.68K | -$131.07K | -$108.83K | |
| -1.78% | -18.49% | -187.69% | -873.77% | -253.09% | |
| USD/shares | $0.00 | $0.00 | — | — | — |
| USD/shares | $0.00 | $0.00 | — | — | — |
| shares | 4.3M | 4.3M | 4.3M | 4.3M | 3.41M |
| shares | 4.3M | 4.3M | 4.3M | 4.3M | 3.41M |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Annual debt figures are established from 10-K filings and updated by subsequent 10-Q and 8-K disclosures. Instrument balances are not summed into a company total unless the filing itself reports that total.
Debt data is being processed. Please check back later.
Revenue Breakdown
Annual revenue as the company disaggregates it in its own XBRL filings. Years a component wasn't reported show a dash.
Share mode is each component's slice of the reported components that year — issuers rarely tag every revenue dollar, so slices need not sum to total revenue.
By Product & Service (USD)
| Component | FY2023 | FY2022 |
|---|---|---|
| Career Planning Experience Sharing and Guidance | $99,599 | — |
| Traditional Culture and Education | $65,022 | $102,002 |